AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21330907 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PRO2000 gel
Number of subjects: 3101
Study 21330907 — intervention group
Group type: EXPERIMENTAL
Intervention: BufferGel
Number of subjects: 3101
Study 21330907 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 3101
Study 21330907 — intervention group
Group type: COMPARATOR
Intervention: No gel
Number of subjects: 3101
Study 19813275 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine (740 mg/m2 intravenously over 15 minutes before each administration of a platinum agent)
Number of subjects: 82
Study 19813275 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 82
Study 19813275 — intervention group
Group type: COMPARATOR
Intervention: C5V (combined cisplatin, 5‐fluorouracil, and vincristine) without amifostine
Number of subjects: 82
Study 19813275 — intervention group
Group type: COMPARATOR
Intervention: C5V without amifostine
Number of subjects: 82
Study 16488829 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV prevention program
Number of subjects: 496
Study 16488829 — intervention group
Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 496
Study 14984396 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (mean dose 26.3 mg)
Number of subjects: 282
Study 14984396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 11679464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg b.i.d. for 6 months
Number of subjects: 60
Study 11679464 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 6 months
Number of subjects: 60
Study 9629687 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 121
Study 9629687 — intervention group
Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 121
Study 9629687 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 121
Study 7848404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive follow-up (chest roentgenography and bone scan every 6 months)
Number of subjects: 1243
Study 7848404 — intervention group
Group type: COMPARATOR
Intervention: Clinical follow-up (physical examination and mammography)
Number of subjects: 1243
Study 7848404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive follow-up
Number of subjects: 1243
Study 7848404 — intervention group
Group type: COMPARATOR
Intervention: Clinical follow-up
Number of subjects: 1243
Study 3414953 — intervention group
Group type: COMPARATOR
Intervention: Conventional suctioning (group I; n = 20; 15 s of endotracheal suction with no mechanical ventilation during suctioning)
Number of subjects: 40
Study 3414953 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoscopic suctioning (group II; n = 20; bronchoscope Olympus 1 T 10; mechanical ventilation during suctioning)
Number of subjects: 40
Study 29843529 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercise
Number of subjects: 70
Study 29843529 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 70
Study 29843529 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercise along with mindfulness
Number of subjects: 70
Study 28379084 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week mindfulness training intervention
Number of subjects: 44
Study 28379084 — intervention group
Group type: COMPARATOR
Intervention: Active control (one hour extra break per week)
Number of subjects: 44
Study 26408735 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 67
Study 26408735 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 67
Study 26408735 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 67
Study 23832078 — intervention group
Group type: COMPARATOR
Intervention: ONS (Oral Nutritional Supplement)
Number of subjects: 60
Study 23832078 — intervention group
Group type: EXPERIMENTAL
Intervention: ONS800 (ONS plus 800 mg beta-alanine)
Number of subjects: 60
Study 23832078 — intervention group
Group type: EXPERIMENTAL
Intervention: ONS1200 (ONS plus 1200 mg beta-alanine)
Number of subjects: 60
Study 21727233 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help intervention for carers (ECHO intervention)
Number of subjects: 0
Study 21727233 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help intervention for carers (ECHO intervention)
Number of subjects: 0
Study 21727233 — intervention group
Group type: COMPARATOR
Intervention: Self-help and guided self-help versions
Number of subjects: 0
Study 19545479 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger treatment program
Number of subjects: 26
Study 16434603 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy and cognitive behavioral therapy
Number of subjects: 66
Study 15541080 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidermal grafting on diabetic foot ulcers without exposed bones (n = 10)
Number of subjects: 38
Study 15541080 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly developed combination therapy for diabetic ulcers with exposed bones (n = 11)
Number of subjects: 38
Study 15541080 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for diabetic ulcers without exposed bones (n = 8)
Number of subjects: 38
Study 15541080 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure for diabetic ulcers with exposed bones (n = 9)
Number of subjects: 38
Study 11384563 — intervention group
Group type: EXPERIMENTAL
Intervention: Emedastine 0.05% eye drops, administered twice daily for 6 weeks
Number of subjects: 222
Study 11384563 — intervention group
Group type: COMPARATOR
Intervention: Levocabastine 0.05% eye drops, administered twice daily for 6 weeks
Number of subjects: 222
Study 9237139 — intervention group
Group type: EXPERIMENTAL
Intervention: Composipost system
Number of subjects: 0
Study 9237139 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel post and composite core
Number of subjects: 0
Study 9237139 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast gold alloy post and gold alloy core
Number of subjects: 0
Study 9237139 — intervention group
Group type: COMPARATOR
Intervention: Endodontically treated tooth only
Number of subjects: 0
Study 7967703 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination of stasis and refreshment of spirit therapeutic group
Number of subjects: 92
Study 7967703 — intervention group
Group type: COMPARATOR
Intervention: Control group treated wholly with Western drugs
Number of subjects: 92
Study 3174738 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (10 mg)
Number of subjects: 9
Study 3174738 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (4 mg)
Number of subjects: 9
Study 3174738 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (8 mg)
Number of subjects: 9
Study 3174738 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine pretreatment
Number of subjects: 9
Study 3174738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31253086 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine (Group RP)
Number of subjects: 46
Study 31253086 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group Con)
Number of subjects: 46
Study 28923140 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIo2 ∼14.1%, equivalent to 3000 m)
Number of subjects: 10
Study 28923140 — intervention group
Group type: COMPARATOR
Intervention: Normobaric normoxia (sea-level)
Number of subjects: 10
Study 28923140 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIo2 ∼14.1%)
Number of subjects: 10
Study 26749726 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Brostrom method repair (Group A)
Number of subjects: 48
Study 26749726 — intervention group
Group type: COMPARATOR
Intervention: Anatomical double-bundle reconstruction with free semitendinosus tendon autograft (Group B)
Number of subjects: 48
Study 23345022 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Employment (SE)
Number of subjects: 157
Study 23345022 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive Employment
Number of subjects: 157
Study 23345022 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 157
Study 21346162 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood-elevating suggestion before ketamine administration
Number of subjects: 100
Study 21346162 — intervention group
Group type: COMPARATOR
Intervention: No suggestion provided (Control)
Number of subjects: 100
Study 18483071 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 0
Study 18483071 — intervention group
Group type: COMPARATOR
Intervention: Older sedentary subjects
Number of subjects: 0
Study 16764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigens prepared from spiral form of H. pylori
Number of subjects: 22
Study 16764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigens prepared from coccoid cells of H. pylori
Number of subjects: 22
Study 16764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Boosted antigens of coccoid cells
Number of subjects: 22
Study 15129697 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior fractal dimension (FD) for FTLD
Number of subjects: 53
Study 15129697 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior fractal dimension (FD) for AD
Number of subjects: 53
Study 15129697 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of anterior to posterior FD for FTLD
Number of subjects: 53
Study 15129697 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of anterior to posterior FD for AD
Number of subjects: 53
Study 15129697 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity of anterior FD and ratio of anterior to posterior FD
Number of subjects: 53
Study 15129697 — intervention group
Group type: EXPERIMENTAL
Intervention: Specificity of anterior FD and ratio of anterior to posterior FD
Number of subjects: 53
Study 11016666 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% BKC applied after 20% SDS
Number of subjects: 54
Study 11016666 — intervention group
Group type: COMPARATOR
Intervention: Water control applied after 20% SDS
Number of subjects: 54
Study 8889949 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium octaborate tetrahydrate applied at 200 micrograms/cm2 on carpet
Number of subjects: 22
Study 8889949 — intervention group
Group type: COMPARATOR
Intervention: Whole-body dosimeters preventing contact with disodium octaborate tetrahydrate
Number of subjects: 22
Study 8889949 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of urine boron levels between groups
Number of subjects: 22
Study 8889949 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct dermal contact with treated carpet
Number of subjects: 22
Study 1504913 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 47
Study 6344034 — intervention group
Group type: EXPERIMENTAL
Intervention: Fendosal 200 mg
Number of subjects: 153
Study 6344034 — intervention group
Group type: EXPERIMENTAL
Intervention: Fendosal 400 mg
Number of subjects: 153
Study 6344034 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 153
Study 6344034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 30953165 — intervention group
Group type: EXPERIMENTAL
Intervention: BCm bonded to glass‐ceramic treated with HFS
Number of subjects: 240
Study 30953165 — intervention group
Group type: EXPERIMENTAL
Intervention: BCm bonded to glass‐ceramic treated with HF
Number of subjects: 240
Study 30953165 — intervention group
Group type: EXPERIMENTAL
Intervention: BCp bonded to glass‐ceramic treated with MDP
Number of subjects: 240
Study 28008092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive PT (45 minutes of intensive exercises/day)
Number of subjects: 104
Study 28008092 — intervention group
Group type: COMPARATOR
Intervention: Soft PT (20-min/d apart from respiratory needs)
Number of subjects: 104
Study 26440233 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.8 mg/kg
Number of subjects: 160
Study 26440233 — intervention group
Group type: COMPARATOR
Intervention: Sodium thiopental 1.5 mg/kg
Number of subjects: 160
Study 24140630 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg per day
Number of subjects: 7863
Study 24140630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7863
Study 24140630 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in TnI levels
Number of subjects: 7863
Study 21169822 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope (n=106)
Number of subjects: 212
Study 21169822 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (n=106)
Number of subjects: 212
Study 19156474 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar conditioning TMS
Number of subjects: 17
Study 19156474 — intervention group
Group type: COMPARATOR
Intervention: Test stimulus (TS) on contralateral motor cortex
Number of subjects: 17
Study 17342995 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangweikang (TWK)
Number of subjects: 90
Study 17342995 — intervention group
Group type: COMPARATOR
Intervention: Domperidone (Control)
Number of subjects: 90
Study 17342995 — intervention group
Group type: COMPARATOR
Intervention: No additional drug (Blank group)
Number of subjects: 90
Study 15112871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin 1 gr. i.v. preoperative and every 8 hrs. during the first day (3 doses) followed by ciprofloxacin 250 mg. oral every 12 hrs until catheter removal.
Number of subjects: 90
Study 15112871 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin 1 gr. i.v. preoperative and at 8 hrs postoperative (2 doses) followed by nitrofurantoin 100 mg. oral every night until catheter removal.
Number of subjects: 90
Study 11487421 — intervention group
Group type: EXPERIMENTAL
Intervention: Attrition prevention intervention
Number of subjects: 654
Study 11487421 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 654
Study 9684126 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg once daily)
Number of subjects: 223
Study 9684126 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 223
Study 7546090 — intervention group
Group type: EXPERIMENTAL
Intervention: Photo method (computer digitization of color slide photographs)
Number of subjects: 450
Study 7546090 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracing method (acetate tracings)
Number of subjects: 450
Study 7546090 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (photo and tracing)
Number of subjects: 450
Study 2460414 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunable dye laser at 577 nm
Number of subjects: 27
Study 2460414 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunable dye laser at 590 nm
Number of subjects: 27
Study 2460414 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunable dye laser at 620 nm
Number of subjects: 27
Study 31147190 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral block
Number of subjects: 105
Study 31147190 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal nerve block
Number of subjects: 105
Study 31147190 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (control group)
Number of subjects: 105
Study 31005596 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg desmetramadol
Number of subjects: 103
Study 31005596 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg tramadol
Number of subjects: 103
Study 31005596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 31005596 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP inhibition with tramadol
Number of subjects: 103
Study 31005596 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP inhibition with desmetramadol
Number of subjects: 103
Study 29092739 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron (200 mg elemental iron/day)
Number of subjects: 308
Study 25280604 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 159
Study 23456922 — intervention group
Group type: EXPERIMENTAL
Intervention: HR-pQCT PR model
Number of subjects: 60
Study 22066459 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenmai injection (0.6 mL x kg(‐1) and physiological saline 100 mL)
Number of subjects: 26
Study 22066459 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (equal volume to Shenmai injection)
Number of subjects: 26
Study 19628730 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 spray of 1.7% estradiol transdermal spray (1.53 mg/spray) once daily for 14 days
Number of subjects: 72
Study 19628730 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 sprays of 1.7% estradiol transdermal spray (1.53 mg/spray) once daily for 14 days
Number of subjects: 72
Study 19628730 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sprays of 1.7% estradiol transdermal spray (1.53 mg/spray) once daily for 14 days
Number of subjects: 72
Study 17019520 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxmarvil (calcitriol 0.5 mug and alendronate 5 mg)
Number of subjects: 199
Study 17019520 — intervention group
Group type: COMPARATOR
Intervention: Alfacalcidol
Number of subjects: 199
Study 17019520 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxmarvil
Number of subjects: 199
Study 12952272 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflation of the oesophageal balloon
Number of subjects: 14
Study 12952272 — intervention group
Group type: COMPARATOR
Intervention: Deflation of the oesophageal balloon
Number of subjects: 14
Study 10949718 — intervention group
Group type: EXPERIMENTAL
Intervention: Actarit treatment for 24 weeks in group I (stages I and II)
Number of subjects: 37
Study 10949718 — intervention group
Group type: EXPERIMENTAL
Intervention: Actarit treatment for 24 weeks in group II (stages III and IV)
Number of subjects: 37
Study 10949718 — intervention group
Group type: EXPERIMENTAL
Intervention: Actarit treatment in group I
Number of subjects: 37
Study 10949718 — intervention group
Group type: EXPERIMENTAL
Intervention: Actarit treatment in group II
Number of subjects: 37
Study 8767154 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen
Number of subjects: 980
Study 8767154 — intervention group
Group type: COMPARATOR
Intervention: Heparin calcine
Number of subjects: 980
Study 8767154 — intervention group
Group type: COMPARATOR
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 980
Study 1351053 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral repeat‐action albuterol sulfate (Proventil Repetabs), 4 mg in the morning and 4‐16 mg at bedtime
Number of subjects: 98
Study 1351053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 4096741 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine retard-tablet (Pidilat retard)
Number of subjects: 12
Study 4096741 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine retard-tablet (marketed formulation)
Number of subjects: 12
Study 31372674 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine aortic arch variant in embolic stroke patients (25.7%)
Number of subjects: 474
Study 31372674 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine arch subtype B in embolic stroke patients (10.5%)
Number of subjects: 474
Study 31372674 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine arch subtype A
Number of subjects: 474
Study 31372674 — intervention group
Group type: EXPERIMENTAL
Intervention: Other commonly observed variant branching patterns of the aortic arch
Number of subjects: 474
Study 29577519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethosuximide (ETX)
Number of subjects: 114
Study 29577519 — intervention group
Group type: COMPARATOR
Intervention: Inactive control (IC)
Number of subjects: 114
Study 27165014 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg
Number of subjects: 196
Study 27165014 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg
Number of subjects: 196
Study 27165014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 24989685 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadolinium injection (0.2 mmol/kg)
Number of subjects: 28
Study 22281833 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh RBC transfusion (≤5 days of storage)
Number of subjects: 100
Study 22281833 — intervention group
Group type: COMPARATOR
Intervention: Standard issue RBC transfusion (26.5 days of storage)
Number of subjects: 100
Study 21061888 — intervention group
Group type: EXPERIMENTAL
Intervention: Brückner test
Number of subjects: 2371
Study 21061888 — intervention group
Group type: EXPERIMENTAL
Intervention: Brückner test with room lights off
Number of subjects: 2371
Study 21061888 — intervention group
Group type: COMPARATOR
Intervention: Conventional vision testing
Number of subjects: 2371
Study 19026803 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene neochordae (loops)
Number of subjects: 129
Study 19026803 — intervention group
Group type: COMPARATOR
Intervention: Leaflet resection
Number of subjects: 129
Study 19026803 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 129
Study 16446745 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus low‐intensity exercise
Number of subjects: 45
Study 16446745 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus high‐intensity exercise
Number of subjects: 45
Study 16446745 — intervention group
Group type: COMPARATOR
Intervention: Diet only
Number of subjects: 45
Study 12652385 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 1248
Study 12652385 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 1248
Study 10463623 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast cereal
Number of subjects: 144
Study 10463623 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 144
Study 10463623 — intervention group
Group type: COMPARATOR
Intervention: No breakfast (control)
Number of subjects: 144
Study 10463623 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee (control)
Number of subjects: 144
Study 10463623 — intervention group
Group type: COMPARATOR
Intervention: Breakfast cereal (control)
Number of subjects: 144
Study 7756796 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous negative extrathoracic pressure ventilation
Number of subjects: 29